{"nct_id":"NCT03303339","title":"Onvansertib in Combination With Either Low-dose Cytarabine or Decitabine in Adult Patients With Acute Myeloid Leukemia (AML)","status":"COMPLETED","status_verified_date":"2022-12","start_date":"2017-11-17","start_date_type":"ACTUAL","primary_completion_date":"2021-11-17","primary_completion_date_type":"ACTUAL","completion_date":"2021-11-17","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["CRDF"]}